News
Verseon Corporation - Verseon presents anticancer agents at AACR 2018
RNS Number: 2162 L Verseon Corporation 18 April 2018 Press release April 18, 2018. Verseon presents anticancer agents targeting multidrug resistant tumors at cancer research conference. Fremont, Calif.-Verseon, a technology-based pharmaceutical company employing a computer-driven platform to develop a diverse drug pipeline, presented new...
RNS Number: 2162 L Verseon Corporation 18 April 2018 Press release April 18, 2018. Verseon presents anticancer agents targeting multidrug resistant tumors at cancer research conference. Fremont, Calif.-Verseon, a technology-based pharmaceutical company employing a computer-driven platform to develop a diverse drug pipeline, presented new...